MindMaze Therapeutics Holding SA
No trades
−1.360 CHF
−17.12 M CHF
8.42 M CHF
120.38 M
About MindMaze Therapeutics Holding SA
Sector
CEO
Alexandre Capet
Website
Headquarters
Geneva
Identifiers
2
ISINCH1251125998
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.
Related stocks
Frequently Asked Questions
The current price of MMTX is 2.260 CHF — it has decreased by −3.83% in the past 24 hours. Watch MindMaze Therapeutics Holding SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange MindMaze Therapeutics Holding SA stocks are traded under the ticker MMTX.
MMTX stock has risen by 115.24% compared to the previous week, the month change is a −19.86% fall, over the last year MindMaze Therapeutics Holding SA has showed a −19.86% decrease.
We've gathered analysts' opinions on MindMaze Therapeutics Holding SA future price: according to them, MMTX price has a max estimate of 3.56 CHF and a min estimate of 3.56 CHF. Watch MMTX chart and read a more detailed MindMaze Therapeutics Holding SA stock forecast: see what analysts think of MindMaze Therapeutics Holding SA and suggest that you do with its stocks.
MMTX reached its all-time high on Dec 15, 2025 with the price of 2.990 CHF, and its all-time low was 0.980 CHF and was reached on Dec 15, 2025. View more price dynamics on MMTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MMTX stock is 6.82% volatile and has beta coefficient of −0.43. Track MindMaze Therapeutics Holding SA stock price on the chart and check out the list of the most volatile stocks — is MindMaze Therapeutics Holding SA there?
Today MindMaze Therapeutics Holding SA has the market capitalization of 344.88 M, it has increased by 718.78% over the last week.
Yes, you can track MindMaze Therapeutics Holding SA financials in yearly and quarterly reports right on TradingView.
MMTX net income for the last half-year is −4.48 M CHF, while the previous report showed −12.56 M CHF of net income which accounts for 64.35% change. Track more MindMaze Therapeutics Holding SA financial stats to get the full picture.
No, MMTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2025, the company has 31 employees. See our rating of the largest employees — is MindMaze Therapeutics Holding SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MindMaze Therapeutics Holding SA EBITDA is −6.44 M CHF, and current EBITDA margin is −60.69%. See more stats in MindMaze Therapeutics Holding SA financial statements.
Like other stocks, MMTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MindMaze Therapeutics Holding SA stock right from TradingView charts — choose your broker and connect to your account.